South Korean Biotech Company Soars in Debut to Become $8 Billion Stock

(Bloomberg) -- SK Biopharmaceuticals Co., a biotechnology arm of SK Group in South Korea, surged to more than double the company’s initially offered price during its trading debut in the nation’s l...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.